Skip to content
pyrovalerone

Structure via PubChem · Public domain (PubChem)

EntityQ410824· pop 17· linked from 1,696 articles

pyrovalerone

Sign in to save

Also known as O-2371, 4-methyl-β-keto-prolintane

Pyrovalerone (Centroton, 4-Methyl-β-keto-prolintane, Thymergix, O-2371) is a central nervous system (CNS) stimulant that acts as a norepinephrine–dopamine reuptake inhibitor (NDRI). It was developed in the 1980s and had briefly been approved in Spain and France for chronic fatigue or lethargy and as an appetite suppressant, but was withdrawn from both markets around 2001 due to safety concerns including problems with abuse and dependence. It is closely related on a structural level to a number of other cathinone stimulants, such as α-PVP, MDPV and prolintane.

Chemical data

Formula
C16H23NO
Molecular weight
245.36 g/mol
IUPAC name
1-(4-methylphenyl)-2-pyrrolidin-1-ylpentan-1-one
SMILES
CCCC(C(=O)C1=CC=C(C=C1)C)N2CCCC2
InChIKey
SWUVZKWCOBGPTH-UHFFFAOYSA-N
XLogP
3.8
Polar surface area
20.3 Ų
H-bond donors
0
H-bond acceptors
2
Formal charge
0

via PubChem

Drug data · ChEMBL

Withdrawn
Max clinical phase
Approved
Molecule type
Small molecule

via ChEMBL · EBI

Wikidata facts

Mass
245.178
Show 5 more facts
Commons category
Pyrovalerone
chemical formula
C₁₆H₂₃NO
canonical SMILES
CCCC(C(=O)C1=CC=C(C=C1)C)N2CCCC2
subject has role
stimulant
MCN code
2933.91.72
Sources (2)

via Wikidata · CC0

~1 min read

Encyclopedic overview

2 sections
Contents
  • See also
  • References

Pyrovalerone (Centroton, 4-Methyl-β-keto-prolintane, Thymergix, O-2371) is a central nervous system (CNS) stimulant that acts as a norepinephrine–dopamine reuptake inhibitor (NDRI). It was developed in the 1980s and had briefly been approved in Spain and France for chronic fatigue or lethargy and as an appetite suppressant, but was withdrawn from both markets around 2001 due to safety concerns including problems with abuse and dependence. It is closely related on a structural level to a number of other cathinone stimulants, such as α-PVP, MDPV and prolintane.

Side effects of pyrovalerone include decreased appetite, anxiety, fragmented sleep or insomnia, and trembling, shaking, or muscle tremors. Withdrawal symptoms following abuse upon discontinuation often results in depression.

Excerpted from Wikipedia’s “pyrovalerone” article, available under the CC BY-SA 4.0 licence.